Sign In
Buy NKTR
$72.76
+2.17 (+3.07%)
At Close: Aug 04, 2026
Best Penny Stocks To Buy Now? 4 Biotech Stocks To Watch
02:06pm, Friday, 07'th Oct 2022
Best penny stocks to buy? Biotech penny stocks are heating up & these 4 might be worth watching now.
PureTech Health confirms ‘possible combination' with Nektar Therapeutics
03:36am, Friday, 07'th Oct 2022
PureTech Health (LSE:PRTC, NASDAQ:PRTC, OTC:PTCHF) PLC has confirmed that it is in talks about a possible tie-up with Nektar Therapeutics (NASDAQ:NKTR), Inc. Responding to press speculation, PureTec
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
10:20am, Thursday, 08'th Sep 2022 Zacks Investment Research
Smart Beta ETF report for XPH
Nektar.ai exits stealth mode to plug CRM data leakages
08:30pm, Tuesday, 06'th Sep 2022
A lot of important data gets lost along the sales pipeline because sales teams use multiple tools, including email, Zoom and WhatsApp, to talk with buyers. Nektar.
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
10:20am, Tuesday, 06'th Sep 2022 Zacks Investment Research
Sector ETF report for XPH
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
02:10pm, Monday, 08'th Aug 2022 Benzinga
Upgrades
For iRobot Corp (NASDAQ:IRBT), JP Morgan upgraded the previous rating of Underweight to Neutral. In the second quarter, iRobot showed an EPS of $0.35, compared to $0.27 from the year-ago qua
Nektar's (NKTR) Q2 Earnings and Revenues Miss Estimates
04:11pm, Friday, 05'th Aug 2022 Zacks Investment Research
Nektar (NKTR) reports dismal second-quarter 2022 results. The company's operating expenses increased due to restructuring expenses of $106.0 million incurred during the quarter.
Nektar's (NKTR) Q2 Earnings and Revenues Miss Estimates
01:33pm, Friday, 05'th Aug 2022
Nektar (NKTR) reports dismal second-quarter 2022 results. The company's operating expenses increased due to restructuring expenses of $106.0 million incurred during the quarter.
Nektar Therapeutics (NKTR) Reports Q2 Loss, Lags Revenue Estimates
10:15pm, Thursday, 04'th Aug 2022 Zacks Investment Research
Nektar (NKTR) delivered earnings and revenue surprises of 15.84% and 7.01%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
SAN FRANCISCO , July 26, 2022 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the second quarter 2022 on Thursday, August 4, 2022, after the close of U.S.-ba
How to Find Penny Stocks to Buy in Summer 2022
03:30pm, Saturday, 16'th Jul 2022 PennyStocks
Use these tips to find penny stocks to buy this Summer
The post How to Find Penny Stocks to Buy in Summer 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
How to Find Penny Stocks to Buy in Summer 2022
11:30am, Saturday, 16'th Jul 2022
Use these tips to find penny stocks to buy this Summer The post How to Find Penny Stocks to Buy in Summer 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Catalyst (CPRX) Stock Jumps 10%: Will It Continue to Soar?
10:01am, Thursday, 14'th Jul 2022 Zacks Investment Research
Catalyst (CPRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in
Expert Ratings for Nektar Therapeutics
07:06pm, Tuesday, 31'st May 2022 Benzinga
Within the last quarter, Nektar Therapeutics (NASDAQ:NKTR) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
1
5
1
1
What to Know About Buying Penny Stocks on May 11th
12:30pm, Wednesday, 11'th May 2022 PennyStocks
Here's what you need to know about trading penny stocks today
The post What to Know About Buying Penny Stocks on May 11th appeared first on Penny Stocks to Buy, Picks, News and Information | PennyS
